SCD and gastric cancer: To investigate whether AKAP8L facilitates GC cell stemness and chemoresistance in SCD1-dependent pathway, SCD1 siRNA or SCD1 inhibitor (CAY10566) were used in AKAP8L-overexpressing GC cells.